While compounded semaglutide may seem like a more affordable alternative, it carries significant risks due to the lack of oversight, making FDA-approved options like Ozempic, Wegovy, and Mounjaro the safer, more reliable choices for weight loss
Even short-term tracking can help identify nutritional gaps before they become a problem
Sources: Weschawalit, S., Thongthip, S., Phutrakool, P., & Asawanonda, P
The adjusted hazard ratio (aHR) for the tirzepatide group compared to the control group was 0.52 (95% CI: 0.280.91, p = 0.001), indicating a significantly decreased risk of suicidal ideation or attempts in patients treated with tirzepatide